From Molecular Mechanisms to Management: Advances in Diabetic Retinopathy and Diabetic Macular Edema

Diabetic retinopathy (DR) is a major microvascular complication of diabetes mellitus (DM) and a leading cause of vision loss worldwide. Several risk factors have been implicated in the development and progression of DR, such as longer duration of diabetes, poor glycemic control, hypertension, dyslipidemia, renal impairment, and smoking. Diabetic macular edema is the main cause of visual impairment in patients with diabetic retinopathy. It is defined by retinal thickening from fluid leakage into the retina and can be visualized with optical coherence tomography (OCT). At the molecular level, chronic hyperglycemia triggers several pathogenic mechanisms, including oxidative stress, inflammation, advanced glycation end product formation, protein kinase C activation, and dysregulated vascular endothelial growth factor (VEGF) signaling, leading to blood–retinal barrier breakdown, microvascular dysfunction, and retinal neurodegeneration. Current therapeutic approaches include laser photocoagulation, intravitreal anti-VEGF agents, and corticosteroids, with ongoing research into novel interventions targeting senolytic agents, integrin antagonists, inhibitors of vascular adhesion protein-1, anti-inflammatory therapies targeting interleukin-6 (IL-6) signaling, and plasma kallikrein inhibitors. This review synthesizes the recent evidence on DR epidemiology, risk factors, pathophysiology, and treatment, highlighting the need for comprehensive risk-based screening and multidisciplinary management to mitigate the growing burden of diabetic eye disease.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-16
DOI
https://doi.org/10.3390/ijms272210290
Primary Topic
Retinal Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

From Molecular Mechanisms to Management: Advances in Diabetic Retinopathy and Diabetic Macular Edema

Antonio Sarría‐Santamera, Yuliya M. Semenova, Yenlik Baiturova
1 links
International Journal of Molecular Sciences
Retinal Diseases and Treatments
article

From Molecular Mechanisms to Management: Advances in Diabetic Retinopathy and Diabetic Macular Edema

Antonio Sarría‐Santamera, Yuliya M. Semenova, Yenlik Baiturova
article en

Abstract

Diabetic retinopathy (DR) is a major microvascular complication of diabetes mellitus (DM) and a leading cause of vision loss worldwide. Several risk factors have been implicated in the development and progression of DR, such as longer duration of diabetes, poor glycemic control, hypertension, dyslipidemia, renal impairment, and smoking. Diabetic macular edema is the main cause of visual impairment in patients with diabetic retinopathy. It is defined by retinal thickening from fluid leakage into the retina and can be visualized with optical coherence tomography (OCT). At the molecular level, chronic hyperglycemia triggers several pathogenic mechanisms, including oxidative stress, inflammation, advanced glycation end product formation, protein kinase C activation, and dysregulated vascular endothelial growth factor (VEGF) signaling, leading to blood–retinal barrier breakdown, microvascular dysfunction, and retinal neurodegeneration. Current therapeutic approaches include laser photocoagulation, intravitreal anti-VEGF agents, and corticosteroids, with ongoing research into novel interventions targeting senolytic agents, integrin antagonists, inhibitors of vascular adhesion protein-1, anti-inflammatory therapies targeting interleukin-6 (IL-6) signaling, and plasma kallikrein inhibitors. This review synthesizes the recent evidence on DR epidemiology, risk factors, pathophysiology, and treatment, highlighting the need for comprehensive risk-based screening and multidisciplinary management to mitigate the growing burden of diabetic eye disease.

International Journal of Molecular SciencesVol. 27(22)
Nazarbayev University (KZ)
Good health and well-being
Retinal Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon